Document is current
Any future updates will be listed below
-
Authors
Demchenko, Ilya https://orcid.org/0000-0001-7876-4981
Sousa-Ho, Rachel L.
Baltazar, Vanessa A.
Tailor, Ishaan https://orcid.org/0009-0008-6998-6150
Roy, Niloy https://orcid.org/0009-0009-3199-6983
Schweizer, Tom A.
Kennedy, Sidney H. https://orcid.org/0000-0001-5339-7185
Boutet, Alexandre
Lozano, Andres M.
Dunlop, Katharine https://orcid.org/0000-0003-4366-7692
Bhat, Venkat https://orcid.org/0000-0002-8768-1173
- License Information
-
More Information
Article History
Received: 15 January 2026
Revised: 19 February 2026
Accepted: 16 March 2026
First Online: 31 March 2026
Competing interests
: RLS, VAB, IT, NR, TAS, and AB have no conflicts of interest. ID is a Vanier Scholar supported by the Canadian Institutes of Health Research (#513715). SHK has received research funding or honoraria from Abbott, Alkermes, Allergan, Boehringer Ingelheim, Brain Canada, Canadian Institutes of Health Research, Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research Fund, Otsuka, Pfizer, Servier, Sunovion, and Xian-Janssen, and has received stock options from Field Trip Health. AML holds the Hudson Chair in Neurosurgery and is a consultant for Abbott, Boston Scientific, and Functional Neuromodulation Inc. KD is supported by an Academic Scholar Award from the Department of Psychiatry, University of Toronto, and has received research support from the Canadian Institutes of Health Research, Brain & Behavior Foundation, St. Michael’s Foundation, and the American Foundation for Suicide Prevention. VB is supported by an Academic Scholar Award from the Department of Psychiatry, University of Toronto, and has received research support from the Canadian Institutes of Health Research, Brain & Behavior Foundation, Ministry of Health Innovation Funds, Royal College of Physicians and Surgeons of Canada, Department of National Defence (Government of Canada), New Frontiers Research Fund, American Foundation for Suicide Prevention, University of Toronto Connaught Funds, University of Toronto EMH Seed Fund, and investigator-initiated trials from Roche Canada, Eisai Canada, Novartis, Associated Medical Services Inc Healthcare, and the National Research Council of Canada.
